Reported 4,824,469 shares, unchanged from the prior quarter.
Reported value -39.6%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-03-31 | 86309750 |
| 2026-06-30 | 155492636 |
| 2026-09-30 | 93932411 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 4,824,469 | 0 (0.0%) | 4.17% | $93,932,411 | 2026-11-16 | |
| Q2 2026 | Unchanged | 4,824,469 | 0 (0.0%) | 7.56% | $155,492,636 | 2026-08-14 | |
| Q1 2026 | New | 4,824,469 | +4,824,469 (0.0%) | 3.66% | $86,309,750 | 2026-05-15 |
Who else reported the position
142 managers reported AKTIS ONCOLOGY INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | Unchanged | 4,835,872 | 0 | 6.99% | $94,154,428 | 3 qtrs |
| EcoR1 Capital LLC This report | Unchanged | 4,824,469 | 0 | 4.17% | $93,932,411 | 3 qtrs |
| Blue Owl Capital Holdings LP | Added | 3,343,827 | +273,608 | 11.89% | $65,104,312 | 3 qtrs |
| T Rowe Price Investment Management Inc | Added | 3,333,026 | +1,281,579 | 0.05% | $64,895,000 | 3 qtrs |
| BlackRock Inc | Added | 2,780,745 | +502,387 | < 0.01% | $54,141,105 | 3 qtrs |
| RTW INVESTMENTS LP | Unchanged | 1,592,043 | 0 | 0.31% | $30,997,077 | 3 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,471,969 | -494,275 | < 0.01% | $28,659,237 | 3 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 1,184,617 | +421,118 | < 0.01% | $23,066,000 | 3 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 1,180,925 | +363,850 | < 0.01% | $22,992,610 | 3 qtrs |
| EVENTIDE ASSET MANAGEMENT LLC | Added | 1,065,000 | +558,000 | 0.29% | $20,735,550 | 3 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 4,824,469
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.